Skip to content

Mannkind MNKD Operating Income

Operating Income at other companies

LQD
Liquidia CorporationLQDA
$61.5M+274%
Tenet Healthcare logo
Tenet HealthcareTHC
$1.3B+37.4%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
-$996K+96.1%
Opko Health logo
Opko HealthOPK
-$51.02M+24.0%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
-$45.34M-2.0%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$2.41M+614%

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's operating income?
Mannkind (MNKD) reported operating income of -$1.67M in Q1 2026.
How has Mannkind's operating income changed year-over-year?
Mannkind's operating income decreased by 107.5% year-over-year, from $22.29M to -$1.67M.
What is the long-term trend for Mannkind's operating income?
Over 3 years (2021 to 2024), Mannkind's operating income has grown at a 15.6% compound annual growth rate (CAGR), from -$47.02M to $72.59M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.